The reduction in price target by BMO Capital, despite maintaining the same rating, could lead to a negative perception among investors, potentially causing a short-term dip in AFRM's stock price. The direct mention and specific action taken by a reputable analyst firm increases the relevance and importance of this news for AFRM investors.